Cargando…
Circulating miR-185 might be a novel biomarker for clinical outcome in patients with dilated cardiomyopathy
B cells contribute to the development of dilated cardiomyopathy (DCM) by inducing myocyte injuries and myocardial fibrosis. Our recent research indicated that microRNA (miR) -185 participated in human B-cell activation. Thus, this study was aimed to explore the relationship between miR-185 and DCM p...
Autores principales: | Yu, Miao, Liang, Wei, Xie, Yu, Long, Qi, Cheng, Xiang, Liao, Yu-Hua, Yuan, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5028782/ https://www.ncbi.nlm.nih.gov/pubmed/27645404 http://dx.doi.org/10.1038/srep33580 |
Ejemplares similares
-
Circulating miR-185-5p as a Potential Biomarker for Arrhythmogenic Right Ventricular Cardiomyopathy
por: Sacchetto, Claudia, et al.
Publicado: (2021) -
Circulating miR-489 as a potential new biomarker for idiopathic
dilated cardiomyopathy
por: Ishiguro, Tomoya, et al.
Publicado: (2021) -
Potentials of the elevated circulating miR-185 level as a biomarker for early diagnosis of HBV-related liver fibrosis
por: Li, Bin-bin, et al.
Publicado: (2016) -
Circulating miR-19b and miR-181b are potential biomarkers for diabetic cardiomyopathy
por: Copier, Camila Uribe, et al.
Publicado: (2017) -
Diagnostic Value of Circulating Extracellular miR-134, miR-185, and miR-22 Levels in Lung Adenocarcinoma-Associated Malignant Pleural Effusion
por: Shin, Yoon Mi, et al.
Publicado: (2014)